(July 10, 2024, 2:51 PM EDT) -- PHILADELPHIA —A Third Circuit U.S. Court of Appeals panel on July 9 upheld a New Jersey federal judge’s decision to freeze the assets of the chief scientific officer of a biopharmaceutical company and several investment funds he operates, agreeing with the judge that the Securities and Exchange Commission had adequately shown that the man had likely sold shares in response to material nonpublic information but disagreeing with the standard the judge used to reach that decision....